Cost-Effectiveness of Anti-retroviral Adherence Interventions for People Living with HIV: A Systematic Review of Decision Analytical Models

[1]  L. Chuah,et al.  Pharmacist-Involved Antiretroviral Stewardship Programs in People Living with HIV/AIDS: A Systematic Review. , 2023, AIDS patient care and STDs.

[2]  P. Sullivan,et al.  Clinic-Integrated Mobile Health Intervention (“JomPrEP” App) to Improve Uptake of HIV Testing and Pre-exposure Prophylaxis Among Men Who Have Sex With Men in Malaysia: Protocol for an Intervention Development and Multiphase Trial , 2022, JMIR research protocols.

[3]  Jennifer L Fagan,et al.  The Boundary of HIV Care: Barriers and Facilitators to Care Engagement Among People with HIV in the United States. , 2022, AIDS patient care and STDs.

[4]  Tak-Lam Wong,et al.  Impact of COVID-19 on the HIV care continuum in Asia: Insights from people living with HIV, key populations, and HIV healthcare providers , 2022, PloS one.

[5]  R. Guy,et al.  Preferences for pre-exposure prophylaxis for HIV: A systematic review of discrete choice experiments , 2022, EClinicalMedicine.

[6]  A. Napoleão,et al.  Adherence to Antiretroviral Therapy in People Living with HIV/AIDS: A Cross-Sectional Study. , 2022, AIDS patient care and STDs.

[7]  A. Scheim,et al.  Barriers and Facilitators to HIV Pre-Exposure Prophylaxis Uptake, Adherence, and Persistence Among Transgender Populations in the United States: A Systematic Review. , 2022, AIDS patient care and STDs.

[8]  Chen Zhang,et al.  An Integrated Conceptual Framework of Behavioral Intervention Technologies to Promote Healthcare Utilization Among Socially-Marginalized Populations in the United States , 2022, Journal of nursing studies and patient care.

[9]  Chilot Desta Agegnehu,et al.  Burden and Associated Factors of Virological Failure Among People Living with HIV in Sub-Saharan Africa: A Systematic Review and Meta-Analysis , 2022, AIDS and Behavior.

[10]  F. Schwendicke,et al.  Cost-effectiveness of Artificial Intelligence as a Decision-Support System Applied to the Detection and Grading of Melanoma, Dental Caries, and Diabetic Retinopathy , 2022, JAMA network open.

[11]  L. Chuah,et al.  Barriers and Enablers for Adherence to Antiretroviral Therapy Among People Living With HIV/AIDS in the Era of COVID-19: A Qualitative Study From Pakistan , 2022, Frontiers in Pharmacology.

[12]  J. Calva,et al.  Increased Rate of Protease Inhibitor-resistance Associated Mutations in Human Immunodeficiency Viruses Infecting Mexicans who had Been Living Abroad. , 2021, Archives of medical research.

[13]  W. Manosuthi,et al.  A retrospective study of survival and risk factors for mortality among people living with HIV who received antiretroviral treatment in a resource-limited setting , 2021, AIDS Research and Therapy.

[14]  M. Saqlain,et al.  Stigma, Social Support, Illicit Drug Use, and Other Predictors of Anxiety and Depression Among HIV/AIDS Patients in Pakistan: A Cross-Sectional Study , 2021, Frontiers in Public Health.

[15]  A. Awaisu,et al.  The economic impact of pharmacist care for people living with HIV/AIDS: A systematic review , 2021, Exploratory research in clinical and social pharmacy.

[16]  M. Saqlain,et al.  The impact of clinical pharmacist services on patient health outcomes in Pakistan: a systematic review , 2021, BMC Health Services Research.

[17]  C. Latkin,et al.  Perceived HIV Treatment Norms Modify the Association Between HIV-Related Stigma and Adherence to Antiretroviral Therapy Among Persons Living with HIV in Baltimore, Maryland , 2021, AIDS and Behavior.

[18]  A. Awaisu,et al.  Effect of pharmacist care on clinical outcomes among people living with HIV/AIDS: A systematic review and meta-analysis. , 2021, Research in social & administrative pharmacy : RSAP.

[19]  Stacey B. Daughters,et al.  Act Healthy: A Randomized Clinical Trial Evaluating a Behavioral Activation Intervention to Address Substance Use and Medication Adherence Among Low-Income, Black/African American Individuals Living with HIV/AIDS , 2021, AIDS and Behavior.

[20]  L. Brown,et al.  A Review of Interventions to Enhance HIV Medication Adherence , 2021, Current HIV/AIDS Reports.

[21]  R. Brathwaite,et al.  Predicting the individualized risk of poor adherence to ART medication among adolescents living with HIV in Uganda: the Suubi+Adherence study , 2021, Journal of the International AIDS Society.

[22]  C. Mihalopoulos,et al.  Cost-effectiveness evidence of mental health prevention and promotion interventions: A systematic review of economic evaluations , 2021, PLoS medicine.

[23]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2021, Systematic Reviews.

[24]  N. Geyer,et al.  Ten years of nurse-initiated antiretroviral treatment in South Africa: A narrative review of enablers and barriers , 2021, Southern African journal of HIV medicine.

[25]  M. Saqlain,et al.  Health-related quality of life and its predictors among adults living with HIV/AIDS and receiving antiretroviral therapy in Pakistan , 2021, Quality of Life Research.

[26]  M. Hudgens,et al.  Modeling Adherence Interventions Among Youth with HIV in the United States: Clinical and Economic Projections , 2021, AIDS and Behavior.

[27]  M. Saqlain,et al.  Translation and cross-cultural adaptation of WHOQOL-HIV Bref among people living with HIV/AIDS in Pakistan , 2021, Health and Quality of Life Outcomes.

[28]  Haily K. Traxler,et al.  Smartphone-based incentives for promoting adherence to antiretroviral therapy: A randomized controlled trial , 2021, Preventive medicine reports.

[29]  Lunthita M. Duthely,et al.  Digitized HIV/AIDS Treatment Adherence Interventions: A Review of Recent SMS/Texting Mobile Health Applications and Implications for Theory and Practice , 2020, Frontiers in Communication.

[30]  S. S. Syed Sulaiman,et al.  Impact of Medication Regimen Simplification on Medication Adherence and Clinical Outcomes in Patients with Long-Term Medical Conditions , 2020, Patient preference and adherence.

[31]  K. Gerling,et al.  Behavioral Theories and Motivational Features Underlying eHealth Interventions for Adolescent Antiretroviral Adherence: Systematic Review , 2020, JMIR mHealth and uHealth.

[32]  K. Gerling,et al.  Behavioral Theories and Motivational Features Underlying eHealth Interventions for Adolescent Antiretroviral Adherence: A Systematic Review (Preprint) , 2020 .

[33]  B. Chi,et al.  Effect of Enhanced Adherence Package on Early ART Uptake Among HIV-Positive Pregnant Women in Zambia: An Individual Randomized Controlled Trial , 2020, AIDS and Behavior.

[34]  Patricia A. Cavazos-Rehg,et al.  The Impact of a Family-Based Economic Intervention on the Mental Health of HIV-Infected Adolescents in Uganda: Results From Suubi + Adherence. , 2020, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[35]  F. Hashmi,et al.  Concerns of HIV-positive migrant workers in COVID-19 pandemic: A call for action , 2020, Journal of global health.

[36]  C. Reback,et al.  Adapting technology-based HIV prevention and care interventions for youth: lessons learned across five U.S. Adolescent Trials Network studies. , 2020, mHealth.

[37]  L. García-Pérez,et al.  Interventions to improve medication adherence in mental health: the update of a systematic review of cost-effectiveness , 2020, International journal of psychiatry in clinical practice.

[38]  G. Kigozi,et al.  The long-term effects of a family based economic empowerment intervention (Suubi+Adherence) on suppression of HIV viral loads among adolescents living with HIV in southern Uganda: Findings from 5-year cluster randomized trial , 2020, PloS one.

[39]  Zixin Wang,et al.  Prevalence and determinants of virological failure, genetic diversity and drug resistance among people living with HIV in a minority area in China: a population-based study , 2020, BMC Infectious Diseases.

[40]  M. Ekstrand,et al.  A Behavioral Adherence Intervention Improves Rates of Viral Suppression Among Adherence-Challenged People Living with HIV in South India , 2020, AIDS and Behavior.

[41]  V. Welch,et al.  Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. , 2019, The Cochrane database of systematic reviews.

[42]  C. Ndour,et al.  HIV screening in men and women in Senegal: coverage and associated factors; analysis of the 2017 demographic and health survey , 2019, BMC Infectious Diseases.

[43]  Xinchan Jiang,et al.  The Cost-Effectiveness of Digital Health Interventions on the Management of Cardiovascular Diseases: Systematic Review , 2019, Journal of medical Internet research.

[44]  John Brazier,et al.  Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report. , 2019, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[45]  Jennifer A. Pellowski,et al.  A Systematic Review and Meta-analysis of Antiretroviral Therapy (ART) Adherence Interventions for Women Living with HIV , 2018, AIDS and Behavior.

[46]  R. Sahabo,et al.  Cost-effectiveness of a combination strategy to enhance the HIV care continuum in Swaziland: Link4Health , 2018, PloS one.

[47]  J. Veenstra,et al.  Cost-effectiveness and Cost-utility of the Adherence Improving Self-management Strategy in Human Immunodeficiency Virus Care: A Trial-based Economic Evaluation , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[48]  Mandy C. Swann.  Economic strengthening for retention in HIV care and adherence to antiretroviral therapy: a review of the evidence , 2018, AIDS Care.

[49]  Fernando Fernandez-Llimos,et al.  Economic impact of medication non-adherence by disease groups: a systematic review , 2018, BMJ Open.

[50]  H. Weiss,et al.  Economic incentives for HIV testing by adolescents in Zimbabwe: a randomised controlled trial , 2017, The lancet. HIV.

[51]  M. Hiligsmann,et al.  Effectiveness and cost-effectiveness of a nurse-delivered intervention to improve adherence to treatment for HIV: a pragmatic, multicentre, open-label, randomised clinical trial. , 2017, The Lancet. Infectious diseases.

[52]  R. Lester,et al.  Economic evaluation of mobile phone text message interventions to improve adherence to HIV therapy in Kenya , 2017, Medicine.

[53]  A. Phillips,et al.  Cost Effectiveness of Potential ART Adherence Monitoring Interventions in Sub-Saharan Africa , 2016, PloS one.

[54]  Jason Kessler,et al.  Impact and Cost-Effectiveness of Hypothetical Strategies to Enhance Retention in Care within HIV Treatment Programs in East Africa. , 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[55]  J. Gomersall,et al.  Conducting systematic reviews of economic evaluations , 2015, International journal of evidence-based healthcare.

[56]  Joshua Caballero,et al.  Cost effectiveness of a computer-delivered intervention to improve HIV medication adherence , 2013, BMC Medical Informatics and Decision Making.

[57]  G. Colombo,et al.  Antiretroviral therapy in HIV-infected patients: a proposal to assess the economic value of the single-tablet regimen , 2013, ClinicoEconomics and outcomes research : CEOR.

[58]  S. Sansom,et al.  Cost Effectiveness of the National HIV/AIDS Strategy Goal of Increasing Linkage to Care for HIV-Infected Persons , 2012, Journal of acquired immune deficiency syndromes.

[59]  Stavros Petrou,et al.  Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting , 2011, BMJ : British Medical Journal.

[60]  D. Fisman,et al.  The Cost-Effectiveness of Directly Observed Highly-Active Antiretroviral Therapy in the Third Trimester in HIV-Infected Pregnant Women , 2010, PloS one.

[61]  M. Weinstein,et al.  Cost-Effectiveness of Preventing Loss to Follow-up in HIV Treatment Programs: A Côte d'Ivoire Appraisal , 2009, PLoS medicine.

[62]  M. Brandeau,et al.  The Cost-Effectiveness of Counseling Strategies to Improve Adherence to Highly Active Antiretroviral Therapy among Men Who Have Sex with Men , 2008, Medical decision making : an international journal of the Society for Medical Decision Making.

[63]  Milton C Weinstein,et al.  Cost-Effectiveness of an Intervention to Improve Adherence to Antiretroviral Therapy in HIV-Infected Patients , 2006, Journal of acquired immune deficiency syndromes.

[64]  J. Benner,et al.  Clinical and Economic Outcomes of Nonadherence to Highly Active Antiretroviral Therapy in Patients With Human Immunodeficiency Virus , 2006, Medical care.

[65]  Milton C Weinstein,et al.  Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. , 2003, The American journal of medicine.

[66]  J. Mauskopf,et al.  Cost-effectiveness league tables , 2003, PharmacoEconomics.

[67]  J. Nixon,et al.  Summarising economic evaluations in systematic reviews: a new approach , 2001, BMJ : British Medical Journal.

[68]  J Michaels,et al.  Cost effectiveness league tables. , 1993, BMJ.

[69]  J. Minx,et al.  Analysing interactions among Sustainable Development Goals with Integrated Assessment Models , 2019, Global Transitions.

[70]  James Thomas,et al.  A web-based tool for adjusting costs to a specific target currency and price year , 2010 .

[71]  J. Hay,et al.  Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES , 2003, Journal of managed care pharmacy : JMCP.